Spectroscopic findings in attention-deficit/hyperactivity disorder: Review and meta-analysis

World Journal of Biological Psychiatry

Volumn 10, Issue 4 PART 2, 2009, Pages 355-365

  Perlov, Evgeniy ^a   Philipsen, Alexandra ^a   Matthies, Swantje ^a   Drieling, Tobias ^a   Maier, Simon ^a   Bubl, Emanuel ^a   Hesslinger, Bernd ^a   Buechert, Martin ^a   Henning, Jurgen ^a   Ebert, Dieter ^a   Tebartz Van Elst, Ludger ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

ADHD; Choline; Glutamate; Magnetic resonance spectroscopy; N acetyl aspartate

Indexed keywords

ATOMOXETINE; CHOLINE; DEXAMPHETAMINE; GLUTAMIC ACID; GLUTAMINE; METHYLPHENIDATE; N ACETYLASPARTIC ACID; PHOSPHORUS 31; PROTON; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; MEMBRANE LIPID; PHOSPHATE;

ATTENTION DEFICIT DISORDER; BASAL GANGLION; CINGULATE GYRUS; CLINICAL TRIAL; CORPUS STRIATUM; HUMAN; META ANALYSIS; METABOLITE; NEUROBIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREFRONTAL CORTEX; REVIEW; SYSTEMATIC REVIEW; ADULT; BRAIN; CHILD; ENERGY METABOLISM; FEMALE; HEMISPHERIC DOMINANCE; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REFERENCE VALUE;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CHILD; DOMINANCE, CEREBRAL; ENERGY METABOLISM; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMBRANE LIPIDS; NEUROTRANSMITTER AGENTS; PHOSPHATES; REFERENCE VALUES;

EID: 77449108486     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970802176032     Document Type: Review

References (70)

1. Aylward EH, Reiss AL, Reader MJ, Singer HS, Brown JE, Denckla MB. 1996. Basal ganglia volumes in children with attention-deficit hyperactivity disorder. J Child Neurol 11:112-115.
2. Barker PB, Hearshen DO, Boska MD. 2001. Single-voxel proton MRS of the human brain at 1.5Tand 3.0T. Magn Reson Med 45:765-769.
3. Bedard AC, Martinussen R, Ickowicz A, Tannock R. 2004. Methylphenidate improves visual-spatial memory in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 43:260-268.
4. Biederman J, Faraone SV. 2005. Attention-deficit hyperactivity disorder. Lancet 366:237-248.
5. Biederman J, Mick E, Faraone SV. 2000. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 157:816-818.
6. Brown TR. 1992. Practical applications of chemical shift imaging. NMR Biomed 5:238-243.
7. Bush G, Valera EM, Seidman LJ. 2005. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol Psychiatry 57:1273-1284.
8. Carlsson A, Hansson LO, Waters N, Carlsson ML. 1999a. A glutamatergic deficiency model of schizophrenia. Br J Psychiatry Suppl 2-6.
9. Carlsson A, Waters N, Carlsson ML. 1999b. Neurotransmitter interactions in schizophrenia-therapeutic implications. Biol Psychiatry 46:1388-1395.
10. Carrey N, MacMaster FP, Sparkes SJ, Khan SC, Kusumakar V. 2002. Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series. J Child Adolesc Psychopharmacol 12:331-336.
11. Carrey N, MacMaster FP, Fogel J, Sparkes S, Waschbusch D, Sullivan S, et al. 2003. Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study. Clin Neuropharmacol 26:218-221.
12. Carrey NJ, MacMaster FP, Gaudet L, Schmidt MH. 2007. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17:11-17.
13. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, et al. 1996. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53:607-616.
14. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. 2002. Developmental trajectories of brain volume abnormalities in children and adolescents with atten-tion-deficit/hyperactivity disorder. J Am Med Assoc 288:1740-1748.
15. Colla M, Ende G, Alm B, Deuschle M, Heuser I, Kronenberg G. 2008. Cognitive MR spectroscopy of anterior cingulate cortex in ADHD: Elevated choline signal correlates with slowed hit reaction times. J Psychiatr Res 42(7):587-595.
16. Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. 2004. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. J Neuropsychiatry Clin Neurosci 16:63-69.
17. Dautry C, Vaufrey F, Broulliet E, Blizat N, Henry PG, Conde F, et al. 2000. Early AT-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cerebral Blood Flow Metab 20:789-799.
18. Desmond JE, Gabrieli JD, Glover GH. 1998. Dissociation of frontal and cerebellar activity in a cognitive task: evidence for a distinction between selection and search. Neuroimage 7:368-376.
19. Fayed N, Modrego PJ. 2005. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Acad Radiol 12:566-569.
20. Fayed N, Modrego PJ, Castillo J, Davila J. 2007. Evidence of brain dysfunction in attention deficit-hyperactivity disorder: a controlled study with proton magnetic resonance spectroscopy. Acad Radiol 14:1029-1035.
21. Freeman JJ, Jenden DJ. 1976. The source of choline for acetylcholine synthesis in brain. Life Sci 19:949-961.
22. Geddes JW, Panchalingam K, Keller JN, Pettegrew JW. 1997. Elevated phosphocholine and phosphatidylcholine following rat entorhinal cortex lesions. Neurobiol Aging 18:305-308.
23. Golla H, Thier P, Haarmeier T. 2005. Disturbed overt but normal covert shifts of attention in adult cerebellar patients. Brain 128:1525-1535.
24. Gujar SK, Maheshwari S, Bjorkman-Burtscher I, Sundgren PC. 2005. Magnetic resonance spectroscopy. J Neuroophthalmol 25:217-226.
25. Gurvitis GV, Shenton ME, Hokama H, Ohta H, Lasko NB, Gilbertson MW, et al. 1996. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 40:1091-1099.
26. Hesslinger B, Thiel T, Tebartz vE, Hennig J, Ebert D. 2001. Attention-deficit disorder in adults with or without hyperactivity: where is the difference? A study in humans using short echo (1)H-magnetic resonance spectroscopy. Neurosci Lett 304:117-119.
27. Jin Z, Zang YF, Zeng YW, Zhang L, Wang YF. 2001. Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: a 1H-magnetic resonance spectroscopy study. Neurosci Lett 315:45-48
28. Kim BN, Lee JS, Cho SC, Lee DS. 2001. Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder. Yonsei Med J 42:19-29.
29. Konrad K, Neufang S, Hanisch C, Fink GR, Herpertz-Dahlmann B. 2006. Dysfunctional attentional networks in children with attention deficit/hyperactivity disorder: Evidence from an event-related functional magnetic resonance imaging study. Biol Psychiatry 59:643-651.
30. Krause J, Dresel SH, Krause KH, La Fougere C, Zill P, Ackenheil M. 2006. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele. World J Biol Psychiatry 7:152-157.
31. Lenartowicz A, McIntosh AR. 2005. The role of anterior cingulate cortex in working memory is shaped by functional connectivity. J Cogn Neurosci 17:1026-1042.
32. MacMasterFP, Carrey N, Sparkes S, KusumakarV. 2003. Proton spectroscopy in medication-free pediatric attention-deficit/hy-peractivity disorder. Biol Psychiatry 53:184-187.
33. Mataro M, Garcia-Sanchez C, Junque C, Estevez-Gonzalez A, Pujol J. 1997. Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neuropsychological and behavioural measures. Arch Neurol 54:963-968.
34. Mega MS, Cummings JL. 1994. Frontal-subcortical circuits and neuropsychiatric disorders. The Journal of Neuropsychiatry and Clinical Neurosciences 6:358-370.
35. Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, et al. 2006. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry 163:316-318.
36. Natsume J, Watabane K, Tadokoro M, Negoro T, Aso K, Nakashima S, et al. 1997. Widespread glucose hypometabolism in patients with hippocampal atrophy: evaluation with f-fluorodeoxyglucose positron emission tomography. Journal of Epilepsy 10:155-160.
37. Nebel K, Wiese H, Stude P, de Greiff A, Diener HC, Keidel M. 2005. On the neural basis of focused and divided attention. Brain Res Cogn Brain Res 25:760-776.
38. Olbrich HM, Valerius G, Rusch N, Buchert M, Thiel T, Hennig J, et al. 2008. Frontolimbic glutamate alterations in first episode schizophrenia: Evidence from a magnetic resonance spectroscopy study. World J Biol Psychiatry 9(1):59-63.
39. Perlov E, Philipsen A, Hesslinger B, Buechert M, Ahrendts J, Feige B, et al. 2007. Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder-a magnet resonance spectroscopy study. J Psychiatr Res 41:934-941.
40. Perlov E, Philipsen A, Tebartz van Elst L, Ebert D, Henning J, Maier S, et al. 2008. Hippocampus and amygdala morphology in adult attention-deficit/ hyperactivity disorder. J Psychiatry Neurosci in press.
41. Plessen KJ, Bansal R, Zhu H, Whiteman R, Amat J, Quackenbush GA, et al. 2006. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 63:795-807.
42. Purdon AD, Rosenberger TA, Shetty HU, Rapoport SI. 2002. Energy consumption by phospholipid metabolism in mammalian brain. Neurochem Res 27:1641-1647.
43. Ross B, Bluml S. 2001. Magnetic resonance spectroscopy of the human brain. Anat Rec 265:54-84.
44. Rusch N, Tebartz van Elst L, Ludaescher P, Wilke M, Huppertz HJ, Thiel T, et al. 2003. A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage 20:385-392.
45. Russell VA, Oades RD, Tannock R, Killeen PR, Auerbach JG, Johansen EB, et al. 2006. Response variability in attention-deficit/hyperactivity disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct 2:30
46. Scherk H, Backens M, Schneider-Axmann T, Usher J, Kemmer C, Reith W, et al. 2007. Cortical neurochemistry in euthymic patients with bipolar I disorder. World J Biol Psychiatry. 2007 Sep 13:1-10. [Epub ahead of print].
47. Schmahmann JD. 2004. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 16:367-378.
48. Schweitzer JB, Faber TL, Grafton ST, Tune LE, Hoffman JM, Kilts CD. 2000. Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. Am J Psychiatry 157:278-280.
49. Schweitzer JB, Lee DO, Hanford RB, Zink CF, Ely TD, Tagamets MA, et al. 2004. Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity. Biol Psychiatry 56:597-606.
50. Semrud-Clikeman M, Steingard RJ, Filipek P, Biederman J, Bekken K, Renshaw PF 2000. Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 39:477-484
51. Sergeant JA, Geurts H, Oosterlaan J. 2002. How specific is a deficit of executive functioning for attention-deficit/hyperactiv-ity disorder? Behav Brain Res 130:3-28.
52. Sesack SR, Carr DB, Omelchenko N, Pinto A. 2003. Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann NY Acad Sci 1003:36-52.
53. Sparkes SJ, MacMaster FP, Carrey NC. 2004. Proton magnetic resonance spectroscopy and cognitive function in pediatric attention-deficit/hyperactive disorder. Brain Cogn 54:173-175.
54. Spencer TJ, Biederman J, Wilens TE, Faraone SV. 2002. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry 63(Suppl 12):3-9.
55. Stanley JA, Kipp H, Greisenegger E, MacMaster FP, Panchalin-gam K, Pettegrew JW, et al. 2006. Regionally specific alterations in membrane phospholipids in children with ADHD: An in vivo 31P spectroscopy study. Psychiatry Res 148:217-221.
56. Stork C, Renshaw PF. 2005. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 10:900-919.
57. Sun L, Jin Z, Zang YF, Zeng YW, Liu G, Li Y, et al. 2005. Differences between attention-deficit disorder with and without hyperactivity: a 1H-magnetic resonance spectroscopy study. Brain Dev 27:340-344.
58. Tebartz van Elst L. 2005. Amygdala morphometry in affective disorders. Am J Psychiatry 162:629.
59. Tebartz van Elst L, Thiel T, Hesslinger B, Lieb K, Bohus M, Hennig J, et al. 2001. Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder. J Neuropsychiatry Clin Neurosci 13:511-514.
60. Tebartz van Elst L, Valerius G, Buchert M, Thiel T, Rusch N, Bubl E, et al. 2005. Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. Biol Psychiatry 58:724-730.
61. Tebartz van Elst L, Ludaescher P, Thiel T, Buchert M, Hesslinger B, Lieb K, et al. 2007. Evidence of disturbed amygdala energy metabolism in patients with borderline personality disorder. Neurosci Lett 417:36-41
62. Tebartz vE, Woermann FG, Lemieux L, Trimble MR. 1999. Amygdala enlargement in dysthymia-a volumetric study of patients with temporal lobe epilepsy. Biol Psychiatry 46:1614-1623
63. Tebartz vE, Woermann F, Lemieux L, Trimble MR. 2000. Increased amygdala volumes in female and depressed humans. A quantitative magnetic resonance imaging study. Neurosci Lett 281:103-106.
64. Todd RD, Botteron KN. 2001. Is attention-deficit/hyperactivity disorder an energy deficiency syndrome? Biol Psychiatry 50:151-158.
65. Townsend J, Courchesne E, Covington J, Westerfield M, Harris NS, Lyden P, et al. 1999. Spatial attention deficits in patients with acquired or developmental cerebellar abnormality. J Neurosci 19:5632-5643.
66. Tzavara ET, Li DL, Moutsimilli L, Bisogno T, Di M, V, Phebus LA, et al. 2006. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Biol Psychiatry 59:508-515.
67. Vance JE. 1988. Compartmentalization of phospholipids for lipoprotein assembly on the basis of molecular species and biosynthetic origin. Biochim Biophys Acta 963:70-81.
68. Yeo RA, Hill DE, Campbell RA, Vigil J, Petropoulos H, Hart B, et al. 2003. Proton magnetic resonance spectroscopy investigation of the right frontal lobe in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 42:303-310.
69. Zametkin AJ, Liebenauer LL, Fitzgerald GA, King AC, Minkunas DV, Herscovitch P, et al. 1993. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 50:333-340.
70. Zetzsche T, Frodl T, Preuss UW, Schmitt G, Seifert D, Leinsinger G, et al. 2006. Amygdala volume and depressive symptoms in patients with borderline personality disorder. Biol Psychiatry 60:302-310.